Appointments advance Australian operations and will build strong connections with medical practitioners
• Three Medical Liaison Managers (MLMs) appointed to drive engagement and educational programs with the medical community
• The Managers bring an extensive knowledge of the chronic pain market and experience representing products for leading pharmaceutical companies
• Advances strategy to provide guidance and educational information to doctors, making AusCann the preferred provider of cannabinoid medicines Australia-wide
• Further builds on the Company’s expert medical team, which includes recently appointed Chief Medical Advisor, Dr Danial Schecter from Canada
AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce it has appointed three Medical Liaison Managers (MLMs), to manage doctor communications and assist in the prescription of AusCann’s cannabinoid medicines in Australia.
For further information please download PDF attached:
Download this document
